We use cookies on our website to provide you with a better service.
More info
Accept all
More options
Functional cookies
Language cookie
Performance cookies
Google Analytics
YouTube
Vimeo
More info
Accept all
Ok
screenreader.back to home
screenreader.open offcanvas menu
Portfolio
Team
News
Contact
back to Capricorn Partners
Capricorn Health
News
rss feed
News
Stay up to date
year
by year
2023
2022
2021
2020
2019
2018
2017
reset
2017
Nexstim Plc appoints Steve Beller as Vice President and General Manager
1 December 2017
Sequana Medical announces results of the MOSAIC trial data presented at 2017 AASLD
24 October 2017
iSTAR Medical completes enrolment of first-in-human MIGS trial
17 October 2017
Sequana Medical announces publication of results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T).
4 October 2017
Confo Therapeutics enters into drug discovery collaboration with Lundbeck
26 September 2017
Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA
27 June 2017
Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation
17 May 2017
Mainstay Medical starts commercialization of ReActiv8® for the treatment of Chronic Low Back Pain
1 February 2017
Confo Therapeutics is awarded € 2.6 million in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology
1 February 2017
Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system
31 January 2017
1
...
3
4
5